- Home
- GEHC vs EQR Comparison
GEHC vs EQR Comparison
Compare GEHC & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEHC | EQR |
|---|---|---|
| Founded | 1892 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Real Estate Investment Trusts |
| Sector | Technology | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 24.3B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GEHC | EQR |
|---|---|---|
| Price | $64.54 | $66.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $88.38 | $69.63 |
| AVG Volume (30 Days) | ★ 6.3M | 2.6M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | 0.24% | ★ 4.29% |
| EPS Growth | 4.84 | ★ 8.09 |
| EPS | ★ 0.85 | 0.24 |
| Revenue | ★ $20,625,000,000.00 | $2,701,075,000.00 |
| Revenue This Year | $7.12 | $4.07 |
| Revenue Next Year | $4.45 | $3.14 |
| P/E Ratio | ★ $75.72 | $276.29 |
| Revenue Growth | ★ 4.84 | 4.76 |
| 52 Week Low | $58.75 | $57.57 |
| 52 Week High | $89.77 | $70.31 |
Technical Indicators
Market Signals| Indicator | GEHC | EQR |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 60.83 |
| Support Level | $60.86 | $63.76 |
| Resistance Level | $75.65 | $66.51 |
| Average True Range (ATR) | 1.69 | 1.10 |
| MACD | 0.69 | -0.08 |
| Stochastic Oscillator | 84.91 | 79.53 |
Price Performance
Historical ComparisonAbout GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 318 apartment communities with over 86,000 units and is developing three additional properties with 935 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.